Model-based for nasopharyngeal carcinoma
September 25, 2020
Video file
Please connect to access this resource and get a more personalized Campus experience
No account yet? Request access
Executive summary
Prof. Hans Langendijk presents the model-based selection procedure for nasopharyngeal carcinoma, IMPT treatment results compared with IMRT or VMAT treatments, delta dose between SPArc and IMPT.
Arc Therapy is currently under research and development phase and will be available for sale when regulatory clearance is received.
Key content topics
Top cancer treatments
Related contents
Proton Therapy Publication
November 2022
Cost-effectiveness of proton radiotherapy versus photon radiotherapy for non-small cell lung cancer patients: Exploring the model-based approach.
Webinar
April 22, 2022
The Model-based Approach
Hans
Langendijk
Proton Therapy Publication
January 2022
Model-Based Selection for PT in Breast Cancer
Proton Therapy Publication
September 2021
Scoping review of patient selection methods for proton therapy
User case
2021
Proton therapy in Groningen: clinical practice and future perspectives
Proton Therapy Publication
25 June 2021
National Protocol for Model-Based Selection for Proton Therapy in Head and Neck Cancer
Proton Therapy Publication
February 2021
Clinical practice vs state-of-the-art research and future visions- Report on the 4D treatment planning workshop for particle therapy
Webinar
November 20, 2020
Managing motion in PT
Erik
Korevaar
Peng
Wang
User meeting
November 19, 2020
Show & Tell #1: Head & Neck
Alexander
Lin
Kevin
Teo
Please connect to access this resource and get a more personalized Campus experience
Login